GemPharmatech Co., Ltd. (SHA:688046)
China · Delayed Price · Currency is CNY 25.46
+1.23 (5.08%)
At close: Jul 10, 2026
GemPharmatech Market Cap
GemPharmatech has a market cap or net worth of 10.41 billion as of July 10, 2026. Its market cap has increased by 104.62% in one year.
Market Cap
10.41B
Enterprise Value
9.59B
Revenue
830.61M
Ranking
n/a
PE Ratio
63.52
Stock Price
25.46
Market Cap Chart
Since April 25, 2022, GemPharmatech's market cap has increased from 7.59B to 10.41B, an increase of 37.28%. That is a compound annual growth rate of 7.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 10.41B | 65.34% |
| Dec 31, 2025 | 6.30B | 19.98% |
| Dec 31, 2024 | 5.25B | -36.47% |
| Dec 29, 2023 | 8.26B | -16.22% |
| Dec 30, 2022 | 9.86B | 30.00% |
| Apr 25, 2022 | 7.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Staidson (Beijing) BioPharmaceuticals | 11.57B |
| Shanghai Medicilon | 11.44B |
| Inner Mongolia Furui Medical Science | 11.42B |
| Tibet Cheezheng Tibetan Medicine | 11.36B |
| Beijing Hotgen Biotech | 10.94B |
| Chengzhi | 10.63B |
| Hualan Biological Vaccine | 10.06B |
| Jiangxi Fushine Pharmaceutical | 9.87B |